![]() |
A US CMO that promised to make cost-effective, generic insulin has been sued by the city where it planned to set up a manufacturing plant. Related news |
Demand is at an all time high according to CRO Chiltern, which reported that its revenue grew more than 16% from the last fiscal year.
Calvert Labs and EyeCRO have teamed up, citing growing demand for integrated early-phase services for ocular drugs.
Logistics company DHL has launched a new temperature controlled air freight service to service for biologics.
Catalent says customers are applying controlled release technology to transform drugs into better treatments across all stages of development as it expands its Kentucky manufacturing site.
Manufacturers’ quality issues were among the most prevalent reasons for drug shortages, according to a survey conducted by the ISPE (International Society for Pharmaceutical Engineering).
ATMI has opened a development and testing lab in the US to let customers test its single-use production and technologies.
The latest technology platform from Capsugel's four-month old DFS Unit offers greater bioavailabilty and stability in oral dose formulation, says the company.
A new sales and marketing manager at tableting tech firm IHolland, and new CFO at Sinovac - that's right, it's In-Pharmatechnologist.com round-up of ladder-climbers in the world of pharmaceuticals.
The European Commission has welcomed the publication of the list of Indian API makers issued with “written confirmations” of quality by the CDSCO.
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference